Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2898532rdf:typepubmed:Citationlld:pubmed
pubmed-article:2898532lifeskim:mentionsumls-concept:C0024660lld:lifeskim
pubmed-article:2898532lifeskim:mentionsumls-concept:C0012274lld:lifeskim
pubmed-article:2898532lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:2898532lifeskim:mentionsumls-concept:C0700308lld:lifeskim
pubmed-article:2898532pubmed:issue7lld:pubmed
pubmed-article:2898532pubmed:dateCreated1988-8-5lld:pubmed
pubmed-article:2898532pubmed:abstractTextA series of cis- and trans-4-carboxy-3,4,5,6-tetrahydropyrimidin-2(1H)-ones possessing either a carboxy, hydroxymethyl, or mercaptomethyl substituent at C-6 were prepared and tested for their ability to inhibit mammalian dihydroorotase. Of these compounds, only the cis-6-mercaptomethyl compound, cis-1, was found to be a potent competitive inhibitor of the enzyme (Ki = 140 nM at pH 7.4 and 8.5) when assayed in the direction of dihydro-L-orotate hydrolysis. These results suggest that the inhibition arises from the ligation of the thiolate to the zinc atom which is thought to be located in the enzyme's active site. Although analysis of cis-1 with 2,2'-dithiobis(5-nitrobenzoic acid) revealed significant loss of the free thiol group under enzymatic assay conditions, the addition of the reducing agent, dithiothreitol, to the enzymatic reaction mixtures afforded cis-1 complete protection against this chemical decomposition, as evidenced by lowering of the inhibition constant in the presence of dithiothreitol. Compound cis-1 had no significant antiproliferative activity against B16 melanoma cells in tissue culture, possibly due to the rapid decomposition of the compound or poor permeability into cells.lld:pubmed
pubmed-article:2898532pubmed:languageenglld:pubmed
pubmed-article:2898532pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2898532pubmed:citationSubsetIMlld:pubmed
pubmed-article:2898532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2898532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2898532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2898532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2898532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2898532pubmed:statusMEDLINElld:pubmed
pubmed-article:2898532pubmed:monthJullld:pubmed
pubmed-article:2898532pubmed:issn0022-2623lld:pubmed
pubmed-article:2898532pubmed:authorpubmed-author:JohnsonR KRKlld:pubmed
pubmed-article:2898532pubmed:authorpubmed-author:AdamsJ LJLlld:pubmed
pubmed-article:2898532pubmed:authorpubmed-author:MetcalfB WBWlld:pubmed
pubmed-article:2898532pubmed:authorpubmed-author:MeekT DTDlld:pubmed
pubmed-article:2898532pubmed:authorpubmed-author:MongS MSMlld:pubmed
pubmed-article:2898532pubmed:issnTypePrintlld:pubmed
pubmed-article:2898532pubmed:volume31lld:pubmed
pubmed-article:2898532pubmed:ownerNLMlld:pubmed
pubmed-article:2898532pubmed:authorsCompleteYlld:pubmed
pubmed-article:2898532pubmed:pagination1355-9lld:pubmed
pubmed-article:2898532pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:2898532pubmed:meshHeadingpubmed-meshheading:2898532-...lld:pubmed
pubmed-article:2898532pubmed:meshHeadingpubmed-meshheading:2898532-...lld:pubmed
pubmed-article:2898532pubmed:meshHeadingpubmed-meshheading:2898532-...lld:pubmed
pubmed-article:2898532pubmed:meshHeadingpubmed-meshheading:2898532-...lld:pubmed
pubmed-article:2898532pubmed:meshHeadingpubmed-meshheading:2898532-...lld:pubmed
pubmed-article:2898532pubmed:meshHeadingpubmed-meshheading:2898532-...lld:pubmed
pubmed-article:2898532pubmed:meshHeadingpubmed-meshheading:2898532-...lld:pubmed
pubmed-article:2898532pubmed:meshHeadingpubmed-meshheading:2898532-...lld:pubmed
pubmed-article:2898532pubmed:meshHeadingpubmed-meshheading:2898532-...lld:pubmed
pubmed-article:2898532pubmed:meshHeadingpubmed-meshheading:2898532-...lld:pubmed
pubmed-article:2898532pubmed:meshHeadingpubmed-meshheading:2898532-...lld:pubmed
pubmed-article:2898532pubmed:meshHeadingpubmed-meshheading:2898532-...lld:pubmed
pubmed-article:2898532pubmed:meshHeadingpubmed-meshheading:2898532-...lld:pubmed
pubmed-article:2898532pubmed:meshHeadingpubmed-meshheading:2898532-...lld:pubmed
pubmed-article:2898532pubmed:meshHeadingpubmed-meshheading:2898532-...lld:pubmed
pubmed-article:2898532pubmed:meshHeadingpubmed-meshheading:2898532-...lld:pubmed
pubmed-article:2898532pubmed:year1988lld:pubmed
pubmed-article:2898532pubmed:articleTitlecis-4-Carboxy-6-(mercaptomethyl)-3,4,5,6-tetrahydropyrimidin-2(1 H)-one , a potent inhibitor of mammalian dihydroorotase.lld:pubmed
pubmed-article:2898532pubmed:affiliationDepartment of Medicinal Chemistry, Smith Kline & French Laboratories, Swedeland, Pennsylvania 19479.lld:pubmed
pubmed-article:2898532pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2898532pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:2898532lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2898532lld:pubmed